1[1]Califf RM,Topol EJ,George BS,et al.Hemorrhagic complications associated with the use of intravenous tissue plasminogen activator in treatment of acute myocardial infarction[J].Am J Med,1988,85(5):353-359.
2[2]De QF,Araujo JO,Veloso HH,et al.Efficacy and safety of abciximab on acute myocardial infarction treated with percutaneous coronary interventions:a meta-analysis of randomized,controlled trials[J].Am Heart J,2004,148 (6):937-943.
